Cargando…

Risk factors for malignant transformation of mature cystic teratoma

OBJECTIVE: The aim of this study was to investigate the preoperative characteristics of benign mature cystic teratoma (MCT) and struma ovarii and their risk factors associated malignancies, and determine the appropriate treatment options for these tumors. METHODS: This was a retrospective study on 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Chan-Hong, Jung, Min-Hyung, Ji, Yong-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663225/
https://www.ncbi.nlm.nih.gov/pubmed/26623411
http://dx.doi.org/10.5468/ogs.2015.58.6.475
_version_ 1782403254537158656
author Park, Chan-Hong
Jung, Min-Hyung
Ji, Yong-Il
author_facet Park, Chan-Hong
Jung, Min-Hyung
Ji, Yong-Il
author_sort Park, Chan-Hong
collection PubMed
description OBJECTIVE: The aim of this study was to investigate the preoperative characteristics of benign mature cystic teratoma (MCT) and struma ovarii and their risk factors associated malignancies, and determine the appropriate treatment options for these tumors. METHODS: This was a retrospective study on 248 patients who were pathologically diagnosed with ovarian MCT, struma ovarii, or malignant transformations of these tumors at Inje University Haeundae Paik Hospital from March 2010 to January 2015. Routinely evaluated results of adnexal masses before surgery were compared. RESULTS: A total of six patients (2.4%) were confirmed to have malignant tumors. Of the struma ovarii patients, two out of five patients (40%) were confirmed to have malignancy. The mean age at the diagnosis of patients with malignant transformation of teratomas was 43.0 years (range, 27 to 67 years), which was higher than that of patients with benign teratomas (36.5 years). The mean diameter of the tumor before surgery in the malignant tumor group was 11.4 cm and larger than 6.5 cm of benign group (P=0.003). The mean CA-125 level in the malignant tumor group was higher than that in the benign tumor group (P=0.01). CONCLUSION: Risk factors for malignant transformation of MCT include elevated CA-125 levels, older age, large tumor masses, and postmenopausal status.
format Online
Article
Text
id pubmed-4663225
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society
record_format MEDLINE/PubMed
spelling pubmed-46632252015-11-30 Risk factors for malignant transformation of mature cystic teratoma Park, Chan-Hong Jung, Min-Hyung Ji, Yong-Il Obstet Gynecol Sci Original Article OBJECTIVE: The aim of this study was to investigate the preoperative characteristics of benign mature cystic teratoma (MCT) and struma ovarii and their risk factors associated malignancies, and determine the appropriate treatment options for these tumors. METHODS: This was a retrospective study on 248 patients who were pathologically diagnosed with ovarian MCT, struma ovarii, or malignant transformations of these tumors at Inje University Haeundae Paik Hospital from March 2010 to January 2015. Routinely evaluated results of adnexal masses before surgery were compared. RESULTS: A total of six patients (2.4%) were confirmed to have malignant tumors. Of the struma ovarii patients, two out of five patients (40%) were confirmed to have malignancy. The mean age at the diagnosis of patients with malignant transformation of teratomas was 43.0 years (range, 27 to 67 years), which was higher than that of patients with benign teratomas (36.5 years). The mean diameter of the tumor before surgery in the malignant tumor group was 11.4 cm and larger than 6.5 cm of benign group (P=0.003). The mean CA-125 level in the malignant tumor group was higher than that in the benign tumor group (P=0.01). CONCLUSION: Risk factors for malignant transformation of MCT include elevated CA-125 levels, older age, large tumor masses, and postmenopausal status. Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2015-11 2015-11-16 /pmc/articles/PMC4663225/ /pubmed/26623411 http://dx.doi.org/10.5468/ogs.2015.58.6.475 Text en Copyright © 2015 Korean Society of Obstetrics and Gynecology http://creativecommons.org/licenses/by-nc/3.0/ Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, Chan-Hong
Jung, Min-Hyung
Ji, Yong-Il
Risk factors for malignant transformation of mature cystic teratoma
title Risk factors for malignant transformation of mature cystic teratoma
title_full Risk factors for malignant transformation of mature cystic teratoma
title_fullStr Risk factors for malignant transformation of mature cystic teratoma
title_full_unstemmed Risk factors for malignant transformation of mature cystic teratoma
title_short Risk factors for malignant transformation of mature cystic teratoma
title_sort risk factors for malignant transformation of mature cystic teratoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663225/
https://www.ncbi.nlm.nih.gov/pubmed/26623411
http://dx.doi.org/10.5468/ogs.2015.58.6.475
work_keys_str_mv AT parkchanhong riskfactorsformalignanttransformationofmaturecysticteratoma
AT jungminhyung riskfactorsformalignanttransformationofmaturecysticteratoma
AT jiyongil riskfactorsformalignanttransformationofmaturecysticteratoma